Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: A matched pair analysis

被引:0
作者
Dahlstrom, KR
Adler-Storthz, K
Etzel, CJ
Liu, ZS
Dillon, L
El-Naggar, AK
Spitz, MR
Schiller, JT
Wei, QY
Sturgis, EM
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[4] Univ Texas, Hlth Sci Ctr, Houston Dent Branch, Houston, TX 77225 USA
[5] NCI, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Infection with human papillomavirus (HPV) type 16 has been suggested to be a risk factor for squamous cell carcinoma of the head and neck (SCCHN) and to be more commonly associated with SCCHN occurring in the oropharynx and in never-smokers. We hypothesized that HPV-16 exposure, as evidenced by seropositivity, is a risk factor for SCCHN and may be of particular importance in never-smokers. Experimental Design: To test this hypothesis, we conducted a hospital-based case-control study of 120 patients with SCCHN (60 never-smokers and 60 matched smokers) and 120 cancer-free matched controls. We compared the presence of HPV-16 antibodies in ever-smoker and never-smoker patients matched on age (+/-5 years), sex, and tumor site. Each patient was also matched with a corresponding ever-smoker or never-smoker cancer-free control on age (+/-5 years) and sex. Serum was collected from study subjects and assayed for IgG reactivity to HPV-16 L1 virus-like particles by using an ELISA. Results: Forty-nine of the 120 case subjects (40.8%) but only 11 (9.2%) of the control subjects tested positive for HPV-16 antibodies (adjusted odds ratio, 6.69; 95% confidence interval, 3.01-14.90). Among cases, HPV-16 seropositivity was more common in those with oropharyngeal cancer (41 of 70, 58.6%) and poorly differentiated tumors (25 of 43, 58.1%). HPV-16 seropositivity was associated with a significantly increased risk of oropharyngeal cancer (adjusted odds ratio, 59.53; 95% confidence interval, 5.71-620.20). Whereas HPV-16 seropositivity was more common in never-smokers with SCCHN than in ever-smokers (43.3% versus 38.3%, respectively), this difference was not statistically significant. Conclusions: HPV-16 infection is associated with a significant increased risk for oropharyngeal cancer but not oral cavity cancer. Furthermore, HPV-16 infection does not appear to be more common in never-smokers than ever-smokers with SCCHN.
引用
收藏
页码:2620 / 2626
页数:7
相关论文
共 50 条
  • [21] Human Papillomavirus Testing in Head and Neck Squamous Cell Carcinoma
    Ferguson, Donna C.
    Mehrad, Mitra
    Ely, Kim A.
    Shinn, Justin R.
    Lewis, James S., Jr.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2021, 145 (09) : 1123 - 1131
  • [22] Oral Tongue Squamous Cell Carcinoma in Never-Smokers: Analysis of Clinicopathologic Characteristics and Survival
    Durr, Megan L.
    van Zante, Annemieke
    Li, David
    Kezirian, Eric J.
    Wang, Steven J.
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2013, 149 (01) : 89 - 96
  • [23] Characterization of Human Papillomavirus 16 Variants in Head-and-Neck Squamous Cell Carcinoma Patients
    Blakaj, D.
    Garg, M.
    Chen, Z.
    Smith, R.
    Prystowsky, M.
    Burk, R.
    Schlecht, N.
    Guha, C.
    Kalnicki, S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S711 - S712
  • [24] p53 mutations in relation to human papillomavirus type 16 infection in squamous cell carcinomas of the head and neck
    Scholes, AGM
    Liloglou, T
    Snijders, PJF
    Hart, CA
    Jones, AS
    Woolgar, JA
    Vaughan, ED
    Walboomers, JMM
    Field, JK
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1997, 71 (05) : 796 - 799
  • [25] Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta-analysis
    Ragin, Camille C. R.
    Taioli, Emanuela
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (08) : 1813 - 1820
  • [26] Role of human papillomavirus infection and other factors in patients with head and neck squamous cell carcinoma
    Iqbal, A.
    Warraich, R.
    Udeabor, S. E.
    Rana, M.
    Eckardt, A. M.
    Gellrich, N-C
    Rana, M.
    [J]. ORAL DISEASES, 2014, 20 (03) : 288 - 293
  • [27] Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck.
    Mork, J
    Lie, AK
    Glattre, E
    Clark, S
    Hallmans, G
    Jellum, E
    Koskela, P
    Moller, B
    Pukkala, E
    Schiller, JT
    Youngman, L
    Lehtinen, M
    Dillner, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (15) : 1125 - 1131
  • [28] Human papillomavirus infection in "young" versus "old" patients with squamous cell carcinoma of the head and neck
    Sisk, EA
    Bradford, CR
    Jacob, A
    Yian, CH
    Staton, KM
    Tang, G
    Harris, MO
    Carey, TE
    Lancaster, WD
    Gregoire, L
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2000, 22 (07): : 649 - 657
  • [29] Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck - Reply
    Mork, J
    Lehtinen, M
    Dillner, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (05) : 377 - 377
  • [30] Molecular analysis of human papillomavirus in never-smokers with non-small cell lung cancer
    Isa, Shun-Ichi
    Kurahara, Yu
    Yamamoto, Satomi
    Tamiya, Akihiro
    Omachi, Naoki
    Asami, Kazuhiro
    Okishio, Kyoichi
    Utsumi, Tomoki
    Ito, Norimasa
    Yoon, Hyung-Eun
    Matsumura, Akihide
    Atagi, Shinji
    Kawaguchi, Tomoya
    [J]. ONCOLOGY LETTERS, 2015, 9 (02) : 927 - 929